Alfuzosin en es it fr

Alfuzosin Brand names, Alfuzosin Analogs

Alfuzosin Brand Names Mixture

  • No information avaliable

Alfuzosin Chemical_Formula


Alfuzosin RX_link

Alfuzosin fda sheet

Alfuzosin FDA

Alfuzosin msds (material safety sheet)

Alfuzosin Synthesis Reference

No information avaliable

Alfuzosin Molecular Weight

389.449 g/mol

Alfuzosin Melting Point

No information avaliable

Alfuzosin H2O Solubility

No information avaliable

Alfuzosin State


Alfuzosin LogP


Alfuzosin Dosage Forms

Tablet (extended-release)

Alfuzosin Indication

For the treatment of the signs and symptoms of benign prostatic hyperplasia.

Alfuzosin Pharmacology

Alfuzosin is an alpha-adrenergic blocking agent used to treat hypertension and benign prostatic hyperplasia. Accordingly, alfuzosin is a selective inhibitor of the alpha1 subtype of alpha adrenergic receptors. In the human prostate, alfuzosin antagonizes phenylephrine (alpha1 agonist)-induced contractions, in vitro, and binds with high affinity to the alpha1c adrenoceptor, which is thought to be the predominant functional type in the prostate. Studies in normal human subjects have shown that alfuzosin competitively antagonized the pressor effects of phenylephrine (an alpha1 agonist) and the systolic pressor effect of norepinephrine. The antihypertensive effect of alfuzosin results from a decrease in systemic vascular resistance and the parent compound alfuzosin is primarily responsible for the antihypertensive activity.

Alfuzosin Absorption

Absorption is 50% lower under fasting conditions

Alfuzosin side effects and Toxicity

side effects are dizziness (due to postural hypotension), upper respiratory tract infection, headache, and fatigue.

Alfuzosin Patient Information


Follow the links

Alfuzosin Organisms Affected

Humans and other mammals